A detailed history of Xponance, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 17,403 shares of HALO stock, worth $835,866. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,403
Previous 17,762 2.02%
Holding current value
$835,866
Previous $930,000 6.99%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$51.3 - $64.42 $18,416 - $23,126
-359 Reduced 2.02%
17,403 $995,000
Q2 2024

Aug 14, 2024

SELL
$37.81 - $52.4 $41,628 - $57,692
-1,101 Reduced 5.84%
17,762 $930,000
Q1 2024

May 13, 2024

BUY
$33.68 - $41.95 $4,412 - $5,495
131 Added 0.7%
18,863 $767,000
Q4 2023

Jan 31, 2024

SELL
$33.32 - $42.1 $5,097 - $6,441
-153 Reduced 0.81%
18,732 $692,000
Q3 2023

Oct 23, 2023

SELL
$36.46 - $44.03 $18,448 - $22,279
-506 Reduced 2.61%
18,885 $721,000
Q2 2023

Jul 13, 2023

SELL
$30.28 - $38.74 $47,479 - $60,744
-1,568 Reduced 7.48%
19,391 $699,000
Q1 2023

Apr 17, 2023

BUY
$32.86 - $55.7 $2,990 - $5,068
91 Added 0.44%
20,959 $800,000
Q4 2022

Jan 23, 2023

SELL
$40.06 - $59.44 $19,389 - $28,768
-484 Reduced 2.27%
20,868 $0
Q3 2022

Oct 24, 2022

BUY
$38.53 - $51.78 $2,620 - $3,521
68 Added 0.32%
21,352 $844,000
Q2 2022

Aug 02, 2022

BUY
$37.35 - $48.3 $25,808 - $33,375
691 Added 3.36%
21,284 $936,000
Q1 2022

Apr 20, 2022

SELL
$31.97 - $41.06 $447 - $574
-14 Reduced 0.07%
20,593 $821,000
Q4 2021

Jan 31, 2022

SELL
$31.82 - $40.75 $20,110 - $25,754
-632 Reduced 2.98%
20,607 $829,000
Q3 2021

Nov 05, 2021

SELL
$38.47 - $46.42 $9,155 - $11,047
-238 Reduced 1.11%
21,239 $864,000
Q2 2021

Aug 12, 2021

BUY
$38.84 - $51.31 $291,377 - $384,927
7,502 Added 53.68%
21,477 $975,000
Q1 2021

May 10, 2021

SELL
$39.51 - $51.45 $121,098 - $157,694
-3,065 Reduced 17.99%
13,975 $583,000
Q4 2020

Feb 11, 2021

BUY
$25.81 - $43.62 $439,802 - $743,284
17,040 New
17,040 $728,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.69B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.